Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES)
Cheng, Y.2; Wu, L.3; Huang, D. Z.4; Wang, Q. M.5; Fan, Y.6; Liu, Z. F.7; Fan, H. J.8; Yao, W. X.9; Liu, B. G.10; Yu, G. H.11
刊名JOURNAL OF THORACIC ONCOLOGY
2022-09-01
卷号17
关键词Trilaciclib SCLC Myelopreservation
ISSN号1556-0864
WOS研究方向Oncology ; Respiratory System
语种英语
出版者ELSEVIER SCIENCE INC
WOS记录号WOS:000858678101207
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129777]  
专题中国科学院合肥物质科学研究院
作者单位1.Guangdong Med Univ, Affiliated Hosp, Zhanjiang, Peoples R China
2.Jilin Canc Hosp, Changchun, Peoples R China
3.Cent South Univ, Hunan Canc Hosp, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China
4.Tianjin Med Univ, Canc Hosp & Inst, Tianjin, Peoples R China
5.Henan Canc Hosp, Zhengzhou, Peoples R China
6.Univ Chinese Acad Sci, Zhejiang Canc Hos, Canc Hosp, Hangzhou, Peoples R China
7.Shandong Canc Hosp & Inst, Shandong, Peoples R China
8.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
9.Sichuan Canc Hosp, Sichuan, Peoples R China
10.Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
推荐引用方式
GB/T 7714
Cheng, Y.,Wu, L.,Huang, D. Z.,et al. Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES)[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17.
APA Cheng, Y..,Wu, L..,Huang, D. Z..,Wang, Q. M..,Fan, Y..,...&Sun, S. G..(2022).Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES).JOURNAL OF THORACIC ONCOLOGY,17.
MLA Cheng, Y.,et al."Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES)".JOURNAL OF THORACIC ONCOLOGY 17(2022).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace